Mandate

Vinge advises VEF Ltd in relation to the group’s change of domicile from Bermuda to Sweden

Vinge has advised VNV Ltd in connection with the process of changing the group’s domicile from Bermuda to Sweden (the “Redomestication”). The Redomestication is carried out by way of a scheme of arrangement under Bermuda law, whereby Swedish Depository Receipts in VEF Ltd are exchanged for shares in the Swedish group entity VEF AB (publ), which constitutes the new parent company of the group following the Redomestication. The shares of VEF AB (publ) is listed on Nasdaq First North Premier Growth Market.

VEF Ltd is an investment company that invests in growth stage private fintech companies. VEF focuses on scale emerging markets and invests across all areas of financial services inclusive of payments, credit, mobile money and wealth advisors.

Vinge’s team consisted of Jesper Schönbeck, Joel Wahlberg, Martin Boström and Anna Svensson (Capital Markets & Public M&A) and Maria Schultzberg (tax).

Related

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of their production facility in Uppsala to Ofichem. The Uppsala site specializes in small-scale, early-phase development work.
August 13, 2025

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025